---
title: "(NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)"
ocid: "ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f"
markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f.md"
json_url: "https://d3tenders.com/contract/ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f.json"
source: "Contracts Finder"
current_stage: "Award"
buyer: "NEWCASTLE UNIVERSITY"
published: "2020-01-30"
---

# (NU/1433 - 7) Sundara Pharmaceuticals Limited - The Provision of Business Consultancy to Assist Commercialisation of University Research. (2)

Buyer: NEWCASTLE UNIVERSITY  
Current stage: Award  
OCID: ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f.json)

## Summary

The latest procurement process involves Newcastle University seeking business consultancy to assist in the commercialisation of university research, specifically related to the provision of consultancy services for Sundara Pharmaceuticals Limited. This initiative falls under the business and management consultancy industry category and is located in the North East of the United Kingdom. Currently, the procurement stage is complete, having concluded with an award date of January 30, 2020, and the contract is set to commence on February 3, 2020, and last until February 2, 2021. The total contract value is £30,000 and was awarded following a selective procurement method under a restricted procedure.

This tender presents significant opportunities for small and medium-sized enterprises (SMEs) that specialise in business consultancy, particularly those with expertise in pharmaceutical research and development. Companies that can demonstrate experience in guiding organisations through pre-clinical trials, regulatory approvals, and product market entry strategies would be particularly well-suited to compete. The connection with Newcastle University also opens avenues for collaborative projects and access to research resources, making this a potentially lucrative engagement for forward-thinking consulting firms.

## Notice

A Professor in Pharmaceutical Chemistry, Roz Anderson joined the University in 1987 and in her 31 year career as a researcher worked on the treatment of Alzheimer's disease, diagnosis of bacterial infections, psoriasis and cancer, but her particular passion was the battle against the rare genetic disorder "Cystinosis". For the last 20 years of her life Roz undertook research to find a better, more efficiently targeted method of delivering cysteamine - which is a toxic and noxious drug used in the management of the rare life limiting genetic disorder Cystinosis. The pre-clinical development of CF10 will provide a GMP-compliant synthetic route, GLP toxicology, toxicokinetic and safety data, and a clinical trial proposal. The results will support a 1st in human CF10 clinical trial. Early pre-clinical trials suggest that the bio-availability of cysteamine delivered by CF10 is twice that achieved by current treatment. This improvement, together with its more efficient mode of delivery, allows for a significant reduction in both the required dose and the frequency of dose, thereby leading to an anticipated reduction in side effects and better adherence to the medication regime. The University established the spin-out company, ''Sundara Pharmaceuticals'', which has been formed with the brief "to enhance the research before undertaking pre-clinical trials, obtaining regulatory approval and either bringing CF10 to market itself or selling to a larger pharma business." The formation of ''Sundara Pharmaceuticals'' facilitated a PS1.56m Medical Research Grant award to undertake preclinical development that will take the drug to prodrug clinical trials, the award runs for a period of 24 months and the project commenced October2018. Sundara would now like to bring in a CEO to support the growth and development of the organisation.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Contracts Finder |
| Latest notice | https://www.contractsfinder.service.gov.uk/Notice/1b15eca4-ad45-4455-862b-9159650eed99 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Works |
| Procurement method | Selective |
| Procurement method details | Restricted procedure |
| Tender suitability | SME |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 30 Jan 2020 |
| Submission deadline | 12 Dec 2019 |
| Future notice date | Not specified |
| Award date | 30 Jan 2020 |
| Contract period | 3 Feb 2020 - 2 Feb 2021 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £30,000 |
| Lots value | Not specified |
| Awards value | £30,000 |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NEWCASTLE UNIVERSITY |
| Locality | NEWCASTLE |
| Post town | Newcastle upon Tyne |
| Postcode | NE1 7RU |
| Country | England |
| ITL 1 | TLC North East (England) |
| ITL 2 | TLC4 Northumberland, Durham and Tyne & Wear |
| ITL 3 | TLC43 Tyneside |
| Local authority | Newcastle upon Tyne |
| Electoral ward | Monument |
| Westminster constituency | Newcastle upon Tyne Central and West |
| Delivery location | TLC North East (England) |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | SAMER TASLAQ |

## CPV Codes

### Divisions

- 79 - Business services: law, marketing, consulting, recruitment, printing and security

### Codes

- 79400000 - Business and management consultancy and related services

## Release History

- 30 Jan 2020 at 10:31 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/1b15eca4-ad45-4455-862b-9159650eed99

## Documents

- https://www.contractsfinder.service.gov.uk/Notice/1b15eca4-ad45-4455-862b-9159650eed99
  30th January 2020 - Awarded contract notice on Contracts Finder

## Notice URLs

- https://www.ncl.ac.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-27936444-9b96-4975-9ada-855b7cc4f57f.json.